Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis-A Longitudinal Study.
antipsychotics
brain age
first-episode psychosis
longitudinal study
machine learning
obesity
Journal
Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760
Informations de publication
Date de publication:
21 10 2021
21 10 2021
Historique:
pubmed:
4
6
2021
medline:
11
2
2022
entrez:
3
6
2021
Statut:
ppublish
Résumé
Obesity is highly prevalent in schizophrenia, with implications for psychiatric prognosis, possibly through links between obesity and brain structure. In this longitudinal study in first episode of psychosis (FEP), we used machine learning and structural magnetic resonance imaging (MRI) to study the impact of psychotic illness and obesity on brain ageing/neuroprogression shortly after illness onset. We acquired 2 prospective MRI scans on average 1.61 years apart in 183 FEP and 155 control individuals. We used a machine learning model trained on an independent sample of 504 controls to estimate the individual brain ages of study participants and calculated BrainAGE by subtracting chronological from the estimated brain age. Individuals with FEP had a higher initial BrainAGE than controls (3.39 ± 6.36 vs 1.72 ± 5.56 years; β = 1.68, t(336) = 2.59, P = .01), but similar annual rates of brain ageing over time (1.28 ± 2.40 vs 1.07±1.74 estimated years/actual year; t(333) = 0.93, P = .18). Across both cohorts, greater baseline body mass index (BMI) predicted faster brain ageing (β = 0.08, t(333) = 2.59, P = .01). For each additional BMI point, the brain aged by an additional month per year. Worsening of functioning over time (Global Assessment of Functioning; β = -0.04, t(164) = -2.48, P = .01) and increases especially in negative symptoms on the Positive and Negative Syndrome Scale (β = 0.11, t(175) = 3.11, P = .002) were associated with faster brain ageing in FEP. Brain alterations in psychosis are manifest already during the first episode and over time get worse in those with worsening clinical outcomes or higher baseline BMI. As baseline BMI predicted faster brain ageing, obesity may represent a modifiable risk factor in FEP that is linked with psychiatric outcomes via effects on brain structure.
Sections du résumé
BACKGROUND
Obesity is highly prevalent in schizophrenia, with implications for psychiatric prognosis, possibly through links between obesity and brain structure. In this longitudinal study in first episode of psychosis (FEP), we used machine learning and structural magnetic resonance imaging (MRI) to study the impact of psychotic illness and obesity on brain ageing/neuroprogression shortly after illness onset.
METHODS
We acquired 2 prospective MRI scans on average 1.61 years apart in 183 FEP and 155 control individuals. We used a machine learning model trained on an independent sample of 504 controls to estimate the individual brain ages of study participants and calculated BrainAGE by subtracting chronological from the estimated brain age.
RESULTS
Individuals with FEP had a higher initial BrainAGE than controls (3.39 ± 6.36 vs 1.72 ± 5.56 years; β = 1.68, t(336) = 2.59, P = .01), but similar annual rates of brain ageing over time (1.28 ± 2.40 vs 1.07±1.74 estimated years/actual year; t(333) = 0.93, P = .18). Across both cohorts, greater baseline body mass index (BMI) predicted faster brain ageing (β = 0.08, t(333) = 2.59, P = .01). For each additional BMI point, the brain aged by an additional month per year. Worsening of functioning over time (Global Assessment of Functioning; β = -0.04, t(164) = -2.48, P = .01) and increases especially in negative symptoms on the Positive and Negative Syndrome Scale (β = 0.11, t(175) = 3.11, P = .002) were associated with faster brain ageing in FEP.
CONCLUSIONS
Brain alterations in psychosis are manifest already during the first episode and over time get worse in those with worsening clinical outcomes or higher baseline BMI. As baseline BMI predicted faster brain ageing, obesity may represent a modifiable risk factor in FEP that is linked with psychiatric outcomes via effects on brain structure.
Identifiants
pubmed: 34080013
pii: 6291438
doi: 10.1093/schbul/sbab064
pmc: PMC8530396
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1772-1781Subventions
Organisme : CIHR
ID : 142255
Pays : Canada
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Int J Obes (Lond). 2019 May;43(5):943-951
pubmed: 30022057
PLoS One. 2014 Jul 18;9(7):e101689
pubmed: 25036617
Obesity (Silver Spring). 2017 Feb;25(2):401-407
pubmed: 28026902
Obesity (Silver Spring). 2016 Sep;24(9):1842-8
pubmed: 27430417
Schizophr Bull. 2013 Nov;39(6):1363-72
pubmed: 23172002
Front Aging Neurosci. 2018 Oct 24;10:317
pubmed: 30405393
World Psychiatry. 2015 Oct;14(3):339-47
pubmed: 26407790
Neurobiol Aging. 2016 Nov;47:63-70
pubmed: 27562529
Curr Pharm Des. 2012;18(4):486-94
pubmed: 22239579
Front Aging Neurosci. 2013 Dec 17;5:90
pubmed: 24381557
Front Hum Neurosci. 2015 Jul 01;9:372
pubmed: 26190989
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31
pubmed: 17909124
Psychiatry Res. 2014 Jan 30;221(1):69-77
pubmed: 24239093
Lancet Psychiatry. 2019 Aug;6(8):675-712
pubmed: 31324560
Aust N Z J Psychiatry. 2012 Aug;46(8):753-61
pubmed: 22761397
J Am Soc Nephrol. 2004 Nov;15(11):2792-800
pubmed: 15504932
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Bipolar Disord. 2020 Aug;22(5):440-460
pubmed: 32356562
Front Neurosci. 2017 Jul 28;11:432
pubmed: 28804444
J Psychiatr Res. 2018 Apr;99:151-158
pubmed: 29454222
Neurobiol Aging. 2014 Feb;35(2):378-86
pubmed: 23998998
J Psychiatr Res. 2020 Nov;130:137-151
pubmed: 32818662
Acta Psychiatr Scand. 2019 Nov;140(5):468-476
pubmed: 31418816
Nature. 2006 Dec 14;444(7121):875-80
pubmed: 17167476
Am J Psychiatry. 2003 Jan;160(1):156-64
pubmed: 12505815
J Neuroinflammation. 2016 Mar 24;13(1):67
pubmed: 27012931
Psychol Med. 2014 Jun;44(8):1591-604
pubmed: 24067252
Psychiatry Res Neuroimaging. 2020 Aug 30;302:111100
pubmed: 32464535
Schizophr Bull. 2013 Mar;39(2):295-305
pubmed: 22927670
Am J Manag Care. 2007 Nov;13(7 Suppl):S170-7
pubmed: 18041878
Neurology. 2005 May 24;64(10):1704-11
pubmed: 15911795
JAMA Psychiatry. 2017 Mar 1;74(3):207-208
pubmed: 28099973
PLoS One. 2013 Jun 27;8(6):e67346
pubmed: 23826273
Arch Gen Psychiatry. 2007 Mar;64(3):297-304
pubmed: 17339518
Eur Neuropsychopharmacol. 2017 Nov;27(11):1153-1162
pubmed: 28867303
Neuroimage. 2015 Nov 15;122:149-57
pubmed: 26256530
Acta Psychiatr Scand. 2015 Aug;132(2):97-108
pubmed: 26016380
Arch Gen Psychiatry. 2011 Jun;68(6):609-16
pubmed: 21300937
Hum Brain Mapp. 2016 Nov;37(11):3745-3756
pubmed: 27400738
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Psychol Med. 2016 Feb;46(3):589-98
pubmed: 26526001
Acta Psychiatr Scand. 2017 Feb;135(2):117-126
pubmed: 27925164
Transl Psychiatry. 2012 Dec 04;2:e200
pubmed: 23212584
Hum Brain Mapp. 2014 Jan;35(1):75-88
pubmed: 23008165
Arch Gen Psychiatry. 1976 Jun;33(6):766-71
pubmed: 938196
Br J Psychiatry. 2010 Feb;196(2):116-21
pubmed: 20118455
J Gerontol A Biol Sci Med Sci. 2017 Jun 1;72(6):825-831
pubmed: 27994005
Eur Heart J. 2019 Jul 21;40(28):2290-2300
pubmed: 30854560
Neuroimage. 2012 Nov 15;63(3):1305-12
pubmed: 22902922
Front Aging Neurosci. 2010 Jul 15;2:
pubmed: 20725527
Bipolar Disord. 2009 Sep;11(6):650-6
pubmed: 19689507
Schizophr Bull. 2015 May;41(3):574-83
pubmed: 25800248
Neuroimage. 2010 Apr 15;50(3):883-92
pubmed: 20070949
Aust N Z J Psychiatry. 2017 May;51(5):500-508
pubmed: 28415873
Schizophr Bull Open. 2020 Jan;1(1):sgaa039
pubmed: 32984819
Br J Psychiatry. 2005 Dec;187:537-43
pubmed: 16319406
Schizophr Bull. 2008 Jan;34(1):30-6
pubmed: 17906336
Neuropsychopharmacology. 2014 Nov;39(12):2910-8
pubmed: 25074491
Schizophr Bull. 2014 Sep;40(5):1140-53
pubmed: 24126515
Schizophr Bull. 2019 Jan 1;45(1):190-198
pubmed: 29272464
Schizophr Bull. 2016 Nov;42(6):1395-1406
pubmed: 26980142
Am J Psychiatry. 1998 Oct;155(10):1384-91
pubmed: 9766770
Am J Psychiatry. 2016 Jun 1;173(6):607-16
pubmed: 26917166
Radiology. 2019 Jun;291(3):763-771
pubmed: 31012815
Schizophr Bull. 2013 Mar;39(2):306-18
pubmed: 22207632
Diabetes Care. 2012 Mar;35(3):488-94
pubmed: 22301128
Neuroradiology. 2019 Jun;61(6):703-710
pubmed: 31011773
JAMA Psychiatry. 2014 Dec 1;71(12):1350-63
pubmed: 25321337
Hum Brain Mapp. 2012 Sep;33(9):2204-10
pubmed: 22887828
Ageing Res Rev. 2015 Mar;20:86-97
pubmed: 24768742
Psychol Med. 2017 Apr;47(6):1030-1040
pubmed: 28032535
Biol Psychiatry. 2011 Oct 1;70(7):672-9
pubmed: 21784414
Front Psychiatry. 2020 Sep 23;11:556759
pubmed: 33173508